- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: States to Recalibrate Hospital Payments; Mumps Outbreak; Tuberculosis Eradication Plan
Some states are rethinking how to compensate hospitals for services, using Medicare reimbursement rates as a benchmark to control costs for state employee health plans; reported cases of mumps are on the rise at Temple University in Philadelphia; the Lancet Commission outlines a new plan for worldwide tuberculosis eradication.
States Use Medicare Reimbursement Rates as a Benchmark to Redesign How Hospitals Are Compensated for Services
States are making efforts to control the costs of state employee health plans by using Medicare reimbursement rates to redesign how they pay hospitals, reported Kaiser Health News. As an example, Dale Folwell, state treasurer of North Carolina, plans to start paying hospitals Medicare rates plus 82%, which he believes will provide hospitals with a modest profit margin while saving the state an estimated $258 million annually. Traditionally, employers or insurers negotiate behind the scenes with hospitals to request discounts to set prices that continue to rise annually and are usually many times higher than the actual cost. Hospital associations opposing the proposition warn of dire consequences, including that hospital revenues could dramatically fall and cause rural hospitals to close.
Cases of Mumps Rising at Temple University
Health officials in Philadelphia now believe 74 individuals have contracted mumps at Temple University, according to the Associated Press. Laboratory testing has confirmed 15 cases, whereas 59 are considered likely due to reported symptoms. The measles, mumps, and rubella vaccine has been recommended by the CDC to prevent the spread of the infection, but research suggests that its effectiveness fades 10 or more years after a second dose is administered. Mumps is a contagious viral infection that causes swollen glands.
Lancet Commission Unveils Plan to End Tuberculosis
The Lancet Commission on tuberculosis proposed a new set of tactics to eradicate the respiratory disease within a generation, STAT News reported. The plan includes investments in rapid diagnostics, vaccine development, and treatment for high-risk populations. These strategies come with a steep price tag as they are predicted to cost an additional $5 billion per year, which would nearly double current international funding to combat the disease. Tuberculosis is responsible for about 4500 deaths per day and is the most deadly infectious disease.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
